The Canadian Cancer Trials Group is a cooperative oncology group which carries out clinical trials...

The Canadian Cancer Trials Group is a cooperative oncology group which carries out clinical trials...
The Canadian HIV Trials Network (CTN) is committed to developing treatments, vaccines and a cure...
Canadian Phase Onward Inc. (CPO) was opened in 2004 due to the growing interest from...
North America's first fully digital hospital, serving the northwestern GTA.
Indoc Research is a not-for-profit focused on catalyzing innovative research partnerships through data. Data should know no bounds. Outputs of research in the agricultural sector can benefit researchers focused on climate change. Research on economic inequality...
Formerly Innovaderm, Indero is a dual-focus CRO specializing in dermatology and rheumatology. With deep expertise in immune-mediated inflammatory diseases, they deliver end-to-end clinical research with a strong patient-centered approach. By combining scientific rigor...
Innovative Medicines Canada represents Canada’s innovative pharmaceutical industry. We help our members discover, develop and deliver innovative medicines and vaccines. Our member companies, which range from fledgling start-ups to established organizations, are...
Inspiration Research Limited (IRL) is an independent company founded in 2003 by Dr. Kenneth Chapman. His vision for Inspiration Research is to educate patients to better manage their diseases and contribute to the advancement of novel therapies. Since inception,...
Founded in 1967, the Institut de recherches cliniques de Montréal (IRCM) / Montreal Clinical Research Institute is a non-profit organization that conducts fundamental and clinical biomedical research in addition to training high-level young scientists. With its...
The Quebec Heart and Lung Institute Research Centre is the only centre funded by the Fonds de recherche du Québec – Santé (FRQS) that regroups three research areas (cardiology, respirology and obesity-metabolism) deemed to be a priority because of the considerable...